Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prospective WCD Post CABG Registry (CABG Registry)
Sponsor: Zoll Medical Corporation
Summary
The primary objective is to observe the rate of recovery of ventricular function (EF\>35%) after first-time coronary artery bypass graft surgery in patients who were prescribed the wearable cardioverter defibrillator (WCD) post-surgery prior to being discharged after hospitalization as part of standard clinical care.
Official title: Prospective WCD Post CABG Registry
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
910
Start Date
2024-09-23
Completion Date
2030-05
Last Updated
2024-11-04
Healthy Volunteers
Not specified
Interventions
WCD
An FDA-approved, CE marked WCD will be prescribed for up to 3 months of use after hospital discharge, with the option for longer use under physician discretion
Locations (4)
Kerckhoff Klinik
Bad Nauheim, Hesse, Germany
Medizinische Hochschule Hannover
Hanover, Lower Saxony, Germany
Sana-Herzzentrum Cottbus GmbH
Cottbus, Germany
Universitätsklinikum Halle (Saale)
Halle, Germany